Orilissa Approved for Moderate to Severe Pain Associated With Endometriosis

By July 24, 2018

The approval was based on data from 2 multinational double-blind, placebo-controlled Phase 3 trials involving 1686 premenopausal women with moderate to severe pain associated with endometriosis.

Long-Term Efficacy Data Show Sustained Pelvic Pain Reduction With Elagolix

By November 01, 2017

No new safety concerns were identified with elagolix use for the 12-month treatment period

Elagolix NDA Submitted for Treating Endometriosis-Associated Pain

By September 06, 2017

Elagolix, an oral gonadotropin-releasing hormone (GnRH) antagonist, was evaluated in two Phase 3 clinical studies in about 1,700 women with moderate-to-severe endometriosis-associated pain.

Dietary Supplements for Dysmenorrhea: Are Any Effective?

By April 07, 2016

A Cochrane review found no high quality evidence to support the efficacy of any dietary supplement for dysmenorrhea.

Ginger May Be Effective for Relieving Primary Dysmenorrhea

July 23, 2015

Meta-analysis shows reduction in pain visual analog score with ginger during days three to four of cycle

First Study Links Chronic Fatigue Syndrome, Early Menopause

February 06, 2015

Menstrual abnormalities, endometriosis, pelvic pain, hysterectomy, and early/surgical menopause are all associated with chronic fatigue syndrome (CFS), according to new research.

First Generic Versions of Celebrex Launched

December 10, 2014

Teva, Mylan, Actavis, and Lupin announced the launch of Celecoxib Capsules, the generic version of Pfizer's Celebrex.

Breckenridge Launches Generic Ponstel

October 14, 2014

Breckenridge announced the launch of Mefenamic Acid 250mg capsules, the generic version of Shionogi's Ponstel.

First Generic Versions of Celebrex Approved

June 02, 2014

The FDA has granted approval for the first generic versions of Celebrex (celecoxib; Pfizer) capsules.

Bleeding Disorder Often Seen With Heavy Menstrual Bleed

October 10, 2013

Bleeding disorders play an important role in both explained and unexplained cases of heavy menstrual bleeding due in many cases to low but not deficient factor XI levels.

Fast-Acting Advil Formulation Hits Store Shelves

August 27, 2013

Pfizer Consumer Healthcare announced the availability of its latest fast acting pain relief medication, Advil (ibuprofen sodium) Film Coated tablets.

Respiratory Symptoms Vary Throughout Menstrual Cycle

December 03, 2012

The frequency of respiratory symptoms, including wheeze, shortness of breath, and cough, varies throughout the menstrual cycle.

ACOG: Menstrual Dysfunction Improves Post-Bariatric Surgery

May 07, 2012

Following bariatric surgery, there is a noticeable improvement seen in menstrual dysfunction and signs of hyperandrogenism.

Four or More PMDD Symptoms Linked With Impairment

March 08, 2012

Women with four or more symptoms of premenstrual dysphoric disorder (PMDD) are likely to experience impairment.

Vitamin D Linked to Reduced Pain in Primary Dysmenorrhea

February 28, 2012

Treatment with cholecalciferol, which rapidly enhances 25-hydroxyvitamin D3 (25[OH]D), is associated with decreased pain and reduced nonsteroidal anti-inflammatory drug (NSAID) use for women with primary dysmenorrhea.

ThermaCare HeatWraps Menstrual product recalled

September 24, 2010

Pfizer Consumer Healthcare announced a voluntary recall of one lot of ThermaCare HeatWraps Menstrual product after a potential leak of the components contained in the wrap was found.

Lysteda available for heavy menstrual bleeding

June 21, 2010

Ferring Pharmaceuticals has launched Lysteda (tranexamic acid tablets) for the treatment of cyclic heavy menstrual bleeding (HMB) in women.